Market Closed -
Bombay S.E.
06:00:53 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
283
INR
|
+0.32%
|
|
-0.37%
|
-12.48%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,148
|
1,864
|
706.8
|
1,843
|
1,723
|
2,172
|
Enterprise Value (EV)
1 |
2,883
|
1,652
|
556.2
|
1,680
|
1,525
|
1,517
|
P/E ratio
|
13.1
x
|
9.36
x
|
5.96
x
|
13.8
x
|
8.31
x
|
8.26
x
|
Yield
|
1.25%
|
2.12%
|
5.59%
|
2.14%
|
1.89%
|
1.75%
|
Capitalization / Revenue
|
2.85
x
|
1.62
x
|
0.77
x
|
2.07
x
|
1.44
x
|
1.4
x
|
EV / Revenue
|
2.61
x
|
1.43
x
|
0.61
x
|
1.89
x
|
1.27
x
|
0.98
x
|
EV / EBITDA
|
10.8
x
|
6.89
x
|
4.62
x
|
11.4
x
|
6.14
x
|
4.45
x
|
EV / FCF
|
30
x
|
25.1
x
|
6.96
x
|
13
x
|
112
x
|
-7.75
x
|
FCF Yield
|
3.33%
|
3.98%
|
14.4%
|
7.67%
|
0.89%
|
-12.9%
|
Price to Book
|
1.92
x
|
1.05
x
|
0.39
x
|
0.96
x
|
1.04
x
|
1.15
x
|
Nbr of stocks (in thousands)
|
13,162
|
13,162
|
13,162
|
13,162
|
10,850
|
10,850
|
Reference price
2 |
239.2
|
141.6
|
53.70
|
140.0
|
158.8
|
200.2
|
Announcement Date
|
8/2/18
|
7/3/19
|
9/2/20
|
7/27/21
|
6/22/22
|
7/4/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,105
|
1,153
|
915.1
|
888.6
|
1,196
|
1,552
|
EBITDA
1 |
267.4
|
239.7
|
120.5
|
147
|
248.4
|
340.8
|
EBIT
1 |
230.8
|
202.2
|
83.09
|
110.3
|
211.9
|
306.4
|
Operating Margin
|
20.89%
|
17.54%
|
9.08%
|
12.41%
|
17.71%
|
19.74%
|
Earnings before Tax (EBT)
1 |
295.1
|
246.9
|
143.5
|
185.4
|
252.7
|
341
|
Net income
1 |
240.5
|
199.3
|
118.7
|
132.6
|
207.4
|
263.1
|
Net margin
|
21.77%
|
17.29%
|
12.97%
|
14.93%
|
17.34%
|
16.96%
|
EPS
2 |
18.27
|
15.14
|
9.017
|
10.11
|
19.12
|
24.25
|
Free Cash Flow
1 |
96.02
|
65.82
|
79.93
|
128.9
|
13.58
|
-195.8
|
FCF margin
|
8.69%
|
5.71%
|
8.73%
|
14.51%
|
1.14%
|
-12.62%
|
FCF Conversion (EBITDA)
|
35.9%
|
27.45%
|
66.34%
|
87.71%
|
5.47%
|
-
|
FCF Conversion (Net income)
|
39.92%
|
33.02%
|
67.35%
|
97.2%
|
6.55%
|
-
|
Dividend per Share
2 |
3.000
|
3.000
|
3.000
|
3.000
|
3.000
|
3.500
|
Announcement Date
|
8/2/18
|
7/3/19
|
9/2/20
|
7/27/21
|
6/22/22
|
7/4/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
264
|
212
|
151
|
163
|
198
|
655
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
96
|
65.8
|
79.9
|
129
|
13.6
|
-196
|
ROE (net income / shareholders' equity)
|
15.7%
|
11.7%
|
6.58%
|
7.77%
|
12.8%
|
14.9%
|
ROA (Net income/ Total Assets)
|
8%
|
6.52%
|
2.58%
|
3.6%
|
7.19%
|
9.6%
|
Assets
1 |
3,008
|
3,058
|
4,607
|
3,686
|
2,884
|
2,742
|
Book Value Per Share
2 |
124.0
|
136.0
|
139.0
|
146.0
|
152.0
|
174.0
|
Cash Flow per Share
2 |
3.670
|
8.180
|
5.980
|
15.40
|
18.30
|
9.900
|
Capex
1 |
37.9
|
54.4
|
40.5
|
3.04
|
91
|
242
|
Capex / Sales
|
3.43%
|
4.72%
|
4.43%
|
0.34%
|
7.6%
|
15.6%
|
Announcement Date
|
8/2/18
|
7/3/19
|
9/2/20
|
7/27/21
|
6/22/22
|
7/4/23
|
|
1st Jan change
|
Capi.
|
---|
| -12.48% | 36.81M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|